Asenapine Maleate Patent Expiration
Asenapine Maleate is Used for treating manic or mixed episodes associated with bipolar disorder and schizophrenia in adult and pediatric patients. It was first introduced by Allergan Sales Llc
Asenapine Maleate Patents
Given below is the list of patents protecting Asenapine Maleate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Saphris |
US7741358 (Pediatric) | Crystal form of asenapine maleate | Oct 06, 2026 | Allergan |
| Saphris |
US8022228 (Pediatric) | Crystal form of asenapine maleate | Oct 06, 2026 | Allergan |
| Saphris | US7741358 | Crystal form of asenapine maleate | Apr 06, 2026 | Allergan |
| Saphris | US8022228 | Crystal form of asenapine maleate | Apr 06, 2026 | Allergan |
| Saphris |
US5763476 (Pediatric) | Sublingual or buccal pharmaceutical composition |
Dec 09, 2020
(Expired) | Allergan |
| Saphris | US5763476 | Sublingual or buccal pharmaceutical composition |
Jun 09, 2020
(Expired) | Allergan |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Asenapine Maleate's patents.
Latest Legal Activities on Asenapine Maleate's Patents
Given below is the list recent legal activities going on the following patents of Asenapine Maleate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 Feb, 2023 | US8022228 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 11 Nov, 2021 | US7741358 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Mar, 2019 | US8022228 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 22 Dec, 2017 | US7741358 |
| Mail-Petition Decision - Accept Late Payment of Maintenance Fees - Granted Critical
| 25 Jul, 2017 | US8022228 |
| Petition Decision - Accept Late Payment of Maintenance Fees - Granted Critical
| 25 Jul, 2017 | US8022228 |
| Petition to Accept Late Payment of Maintenance Fee Payment Filed Critical
| 25 Jul, 2017 | US8022228 |
| Expire Patent Critical
| 16 Oct, 2015 | US8022228 |
| Information Disclosure Statement (IDS) Filed Critical
| 17 Jul, 2012 | US8022228 |
| Recordation of Patent Grant Mailed Critical
| 20 Sep, 2011 | US8022228 |
Asenapine Maleate's Family Patents
